Oncosil Medical Ltd
ASX:OSL
Prices of ASX stocks are not being updated. The latest OSL price on Alpha Spread is from Oct 14, 2026. Financials, forecasts and intrinsic value keep updating.
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Oncosil Medical Ltd
ASX:OSL
|
AU |
|
F
|
Friwo AG
F:CEA
|
DE |
|
G
|
Galderma Group AG
OTC:GDERF
|
CH |
|
Ramayana Lestari Sentosa Tbk PT
IDX:RALS
|
ID |
|
U
|
UniCredit SpA
OTC:UNCFF
|
IT |
|
AB Science SA
PAR:AB
|
FR |
Intrinsic Value
Is OSL undervalued or overvalued?
See the intrinsic value estimate for Oncosil Medical Ltd and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Oncosil Medical Does
Oncosil Medical makes a cancer treatment device used by doctors to deliver tiny radioactive particles directly into tumors, mainly for pancreatic cancer and some nearby biliary cancers. Its product is placed through a standard medical procedure and is designed to target the tumor from inside the body rather than through whole-body radiation.
- Headquarters
- Australia AU
- IPO date
- Aug 15, 2005
Earnings Waterfall
Oncosil Medical Ltd
The intrinsic value for Oncosil Medical Ltd (OSL) under the Base Case is hidden AUD.
Compared with the last price of 0.72 AUD on Oct 14, the stock appears hidden.